ID: ALA4752854

Max Phase: Preclinical

Molecular Formula: C9H15NO

Molecular Weight: 153.22

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  OC1C=CCN(C2CCC2)C1

Standard InChI:  InChI=1S/C9H15NO/c11-9-5-2-6-10(7-9)8-3-1-4-8/h2,5,8-9,11H,1,3-4,6-7H2

Standard InChI Key:  VNPZIRLVUXFELS-UHFFFAOYSA-N

Associated Targets(non-human)

Choline trimethylamine-lyase 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 153.22Molecular Weight (Monoisotopic): 153.1154AlogP: 0.77#Rotatable Bonds: 1
Polar Surface Area: 23.47Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.12CX LogP: 0.83CX LogD: -0.90
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.56Np Likeness Score: 1.01

References

1. Bollenbach M,Ortega M,Orman M,Drennan CL,Balskus EP.  (2020)  Discovery of a Cyclic Choline Analog That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria.,  11  (10): [PMID:33062182] [10.1021/acsmedchemlett.0c00005]

Source